- Nonalcoholic fatty liver disease and non-liver comorbidities
-
Manikat R, Nguyen MH
- KMID: 2539793
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):s86-s102.
- doi: 10.3350/cmh.2022.0442
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by excess fat accumulation in the liver. It is closely associated with metabolic syndrome, and patients with NAFLD often... -
- CITED
-
- Close
- SHARE
-
- Close
- Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
-
Rouillard NA, Barnett SD, Zhang X, Kam L, Manikat R, Cheung R, Nguyen MH
- KMID: 2563422
- Clin Mol Hepatol.
- 2025 Jan;31(1):227-239.
- doi: 10.3350/cmh.2024.0564
Background/Aims: With the obesity pandemic, metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease and a leading cause of end-stage liver disease and liver-related deaths in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018–2023
-
Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A
- KMID: 2560084
- Clin Mol Hepatol.
- 2024 Oct;30(4):756-770.
- doi: 10.3350/cmh.2024.0318
Backgrounds/Aims: The trends in mortality of hepatocellular carcinoma (HCC) and biliary tract cancers stratified by sex and race/ethnicity in the US continue to evolve. We estimated the sex- and race/ethnicity-based... -
- CITED
-
- Close
- SHARE
-
- Close
